Trip or No Trip? The Diverging Development of Psychedelic Drugs for Mental Health (Subscription required) Adrienne Rivlin Read more
Article Life Sciences & Pharma Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors July 2, 2024
Published Articles Marketing & Sales How Can Businesses Survive the ‘Cookie Apocalypse’? April 25, 2024
Executive Insights Life Sciences & Pharma Research Tools and Diagnostics: Outlook and Industry Trends in 2024 March 14, 2024
Executive Insights Diagnostics, Tools and Personalized Medicine Autologous Cell Therapy: Key Challenges and Bioprocessing Innovations February 7, 2024
Executive Insights Life Sciences & Pharma Optimizing Pharmaceutical Portfolios Through M&A January 16, 2024